Whistleblower Claims and Excess Mortality Data Spark Debate on Covid-19 Vaccine Safety
On March 19, former Pfizer toxicologist Dr. Helmut Sterz addressed the German parliament, stating that the Comirnaty vaccine, also known as the Pfizer-BioNTech Covid-19 shot, should never have been approved. He cited skipped long-term toxicology studies, incomplete carcinogenicity testing, and use of a different manufacturing formula in mass production versus clinical trials. He estimated 20,000 to 60,000 vaccine-related deaths in Germany alone, referencing Pfizer’s early post-marketing data and underreporting factors at the Paul Ehrlich Institute.
Infant Mortality Increase
In related news, on April 15, Nicolas Hulscher, an epidemiologist, posted U.S. Centers for Disease Control and Prevention (CDC) data showing what he described as a greater-than-50-percent excess infant mortality rate years after the 2021 mRNA vaccination campaign targeting young women. He noted Mississippi’s recent public-health emergency declaration over rising infant deaths, and linked the trend to “transgenerational” effects of mRNA products. Hulscher cited a reversal of a 30-year decline in U.S. infant mortality that began immediately after the rollout, with causes mirroring those seen in vaccinated adults, and referenced a recent study suggesting possible transfer of mRNA genetic material to offspring.
The German testimony occurred during an ongoing parliamentary review of the pandemic response. Meanwhile, the CDC is trying to downplay infant-mortality statistics by saying that they involve multiple factors, including healthcare access. (One ploy is assigning “institutional racism” as the underlying cause for excess mortality rates, blaming historical discrimination as the reason for diminished healthcare access for minorities.) In the meantime, scientific literature on potential mRNA transgenerational effects remains limited and contested.
Vaccine Proponents Doubling Down
Health authorities are still doubling down and maintaining that Covid-19 vaccines had benefits deemed to outweigh risks for most populations during the pandemic. Critics, however, argue for greater transparency on manufacturing differences, informed consent, and underreported injuries.
This article is part of The New American’s weekly online newsletter Insider Report, which is emailed to TNA subscribers each week. Click here to subscribe to The New American to receive the Insider Report and access exclusive content.
